WEDNESDAY, Dec. 11, 2019 -- Policies that reduce drinking may lower rates of alcohol-related cancers, researchers say.
"When thinking about cancer risk and cancer prevention, the focus tends to be on individual-level risk factors rather than environmental determinants of cancer, like public policies that affect the consumption of alcohol or tobacco," said study co-author Dr. Timothy Naimi.
WEDNESDAY, Dec. 11, 2019 (American Heart Association News) -- When Arctic weather is on the way, forecasters often alert you to protect your pets or watch out on the roads. Perhaps they also should warn you about your heart.
Winter cold and other seasonal factors raise the risk of heart attacks and more. It's an issue whether you're in frigid Alaska or sunny California.
WEDNESDAY, Dec. 11, 2019 -- Two experimental drugs show real promise against an aggressive, treatment-resistant form of breast cancer that's spread to other parts of the body, researchers say.
The tumors in question are called metastatic HER2-positive breast cancers -- named because the tumor cells' surface is populated with a protein called HER2, which is tied to cancer growth. HER2-positive breast cancers account for 15% to 20% of all breast cancers.
WEDNESDAY, Dec. 11, 2019 -- If you're the kind of person who sleeps nine or more hours a night or takes long afternoon naps, you may want to worry about your stroke risk, a new Chinese study suggests.
According to the research, people who sleep and nap too long may increase their risk for stroke by 85%. Regular 90-minute midday naps can raise the risk 25%, compared with not napping or napping for only 30 minutes.
WEDNESDAY, Dec. 11, 2019 -- When your doctor prescribes an antibiotic, there's a 43% chance it may not be needed, a new study finds.
"While there has been a lot of research looking at inappropriate prescribing, our findings suggest that we still may be underestimating the proportion of prescriptions that are inappropriate," said lead study author Michael Ray, a researcher at Oregon State University College of Pharmacy.
WEDNESDAY, Dec. 11, 2019 -- Some patients in remission from the blood cancer called follicular lymphoma can be considered cured, a new small study suggests.
Using DNA sequencing, researchers were able to test the patients' blood to see if mutations that caused the cancer were still present two years after treatment. If these mutations aren't found, the patient can be given a clean bill of health, the study authors said.